Manorama Industries Limited approved a total share capital increase of up to ₹70 crore across six wholly-owned subsidiaries during its board meeting on September 4, 2026. The infusions target operations in Ghana, Nigeria, Burkina Faso, Chad, Brazil, and the UAE to meet working capital requirements.

The company also appointed Dr. Rohini Tiwari as an additional non-executive independent director for a five-year term starting September 4, 2026. The board noted the completion of Mr. Mudit Kumar Singh’s tenure as an independent director effective September 5, 2026.

Subsidiary Capital Infusions

The board authorized cash subscriptions to increase the share capital of its international trading subsidiaries. The transactions are structured as related-party deals on an arm’s-length basis.

The funds are intended for working capital and general corporate purposes. The company plans to deploy capital in a phased manner aligned with business milestones.

What the Numbers Show

The capital allocation highlights a divergence between established revenue generators and new market entries. While Manorama Savanna Ghana Limited recorded a turnover of approximately ₹160 crore in FY25-26, four of the six subsidiaries received significant capital injections despite reporting nil turnover. This suggests the ₹70 crore outlay is primarily focused on scaling infrastructure in newer jurisdictions like Chad, Burkina Faso, and the UAE rather than just supporting existing high-volume operations.

Governance Updates

Dr. Rohini Tiwari brings expertise in food science, nutrition, and quality assurance from her previous roles at Hindustan Coca-Cola Beverages Pvt. Ltd., Ganga Hospital, and Dr. Reddy’s Laboratories. She will serve until September 3, 2031, subject to member approval via postal ballot.

The postal ballot notice will be sent electronically to members registered as on September 11, 2026. M/s Mehta & Mehta were appointed as scrutinizers, and MUFG Intime India Private Limited will provide the e-voting platform.

Manorama Industries has published the notice for its 21st Annual General Meeting in Business Standard and Loksatta on August 28, 2026. The meeting is scheduled for Monday, September 21, 2026, following a record-breaking financial year where standalone revenue from operations grew 76.1% to ₹1,358 crore.

The filing was made pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Deepak Sharma confirmed the submission. The annual report and AGM notice are available on the company's website and on the MUFG Intime India Private Limited platform.

Meeting Details

Key Agenda Items

The notice convening the meeting outlines several ordinary and special business items for shareholder approval.

Final Dividend Recommendation

The Board of Directors, at its meeting held on May 11, 2026, recommended a final dividend of ₹0.80 (Rupees Eighty paisa only) per equity share on a face value of ₹2 each for the financial year ended March 31, 2026. This represents a 40% payout ratio. If approved by members at the AGM, the dividend will be paid to shareholders on record as of Monday, September 14, 2026. The payment is scheduled to be made on or before Tuesday, October 20, 2026.

Director Re-appointment

Shareholders are asked to appoint Mr. Gautam Kumar Pal (DIN: 07645652), Whole-Time Director, in place of himself who retires by rotation. He is eligible and offers himself for re-appointment. Mr. Pal holds a Doctorate in Management and an MBA in Production and Marketing. He has been with the company since January 10, 2018.

Cost Auditor Ratification

The meeting will seek ratification of the remuneration payable to M/s. S N & Co, Cost Accountants, appointed as Cost Auditors for the financial year ending March 31, 2027. The approved remuneration is ₹1,00,000 plus applicable taxes and out-of-pocket expenses.

Material Related Party Transaction

The company seeks approval for material related party transactions with Manorama Africa Limited, where directors have significant influence. The proposed transaction involves the purchase of raw materials and services valued at ₹200 crore for the period from the 21st AGM until the conclusion of the 22nd AGM in FY27.

Manorama Africa Limited, based in Ghana, procures Shea Nuts and other raw materials. The annual consolidated turnover of Manorama Industries for FY26 was ₹1,366.74 crore, setting the materiality threshold at ₹136.67 crore. Transactions with Manorama Africa Limited during FY26 totalled ₹191.75 crore.

FY26 Financial Performance

The integrated annual report highlights FY26 as the company's strongest financial year on record, with standalone revenue from operations reaching ₹1,358 crore, a 76.1% increase year-on-year.

Net cash flow from operations reached ₹259.4 crore. Annual Cash Profit of ₹258.77 crore exceeded Gross Block of ₹250.85 crore for the first time in the company's history. CBE contribution to revenue increased to approximately 30%, while value-added products represented 70–75% of total sales.

Capacity and Strategic Expansion

During FY26, the company debottlenecked Solvent Fractionation Plant 2 (SF2), increasing its capacity 30% from 25,000 MTPA to 32,500 MTPA, raising total fractionation capacity to 47,500 MTPA. The company has initiated a ~₹460 crore phased capex programme targeting commissioning by FY28, encompassing a new 75,000 MTPA Cocoa Butter Alternative facility, a 75,000 MTPA Solvent Fractionation facility (SF3), a 90,000 MTPA refinery in India, and a 90,000 MTPA Shea and Mango processing facility in Burkina Faso.

As of May 2026, ₹52 crore had been deployed from internal accruals. The company raised ₹500 crore through a Qualified Institutional Placement, with allotment of 34,01,360 equity shares on July 2, 2026. The company's credit rating was upgraded to CARE A+: Stable.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE00VM01036/e08e4ff2-e993-43bd-b040-e9cda2200fd9.pdf